AR042015A1 - GENETIC MARKER RELATED TO THE CAPACITY OF PRODUCING SULFHYDIC ACID FOR DAMAGED BACTERIAL VACCINES - Google Patents
GENETIC MARKER RELATED TO THE CAPACITY OF PRODUCING SULFHYDIC ACID FOR DAMAGED BACTERIAL VACCINESInfo
- Publication number
- AR042015A1 AR042015A1 ARP030104114A ARP030104114A AR042015A1 AR 042015 A1 AR042015 A1 AR 042015A1 AR P030104114 A ARP030104114 A AR P030104114A AR P030104114 A ARP030104114 A AR P030104114A AR 042015 A1 AR042015 A1 AR 042015A1
- Authority
- AR
- Argentina
- Prior art keywords
- ability
- mutation
- bacteria
- bacterium
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/42—Salmonella
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se describen bacterias genéticamente alteradas atenuadas deficientes en la capacidad de producir sulfuro de hidrógeno (H2S) para utilizar como vacunas vivas o vectores vivos que pueden administrarse a un organismo huésped para proporcionar inmunidad frente a una enfermedad o para proporcionar otro producto o función genética beneficiosa. Las bacterias genéticamente alteradas de la presente pueden distinguirse fácilmente de otras bacterias mediante un fenotipo H2S negativo cuando se incuba en o de otro modo se contacta con un medio utilizado para detectar la producción de H2S en bacterias. Reivindicación 1: Una bacteria genéticamente alterada deficiente en la capacidad de producir sulfuro de hidrógeno (H2S) que comprende: (a) una primera mutación la cual atenúa la virulencia de dicha bacteria hacia un organismo huésped, donde dicha primera mutación no afecta la capacidad de dicha bacteria de producir H2S, y (b) una segunda mutación, donde dicha mutación torna a la bacteria deficiente en la capacidad de producir H2S.Attenuated genetically altered bacteria deficient in the ability to produce hydrogen sulfide (H2S) to be used as live vaccines or live vectors that can be administered to a host organism to provide immunity against a disease or to provide another beneficial genetic product or function are described. Genetically altered bacteria of the present can be easily distinguished from other bacteria by a negative H2S phenotype when incubated in or otherwise contacted by a means used to detect the production of H2S in bacteria. Claim 1: A genetically altered bacterium deficient in the ability to produce hydrogen sulfide (H2S) comprising: (a) a first mutation which attenuates the virulence of said bacterium towards a host organism, wherein said first mutation does not affect the ability of said bacterium producing H2S, and (b) a second mutation, wherein said mutation makes the bacterium deficient in the ability to produce H2S.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42495202P | 2002-11-08 | 2002-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR042015A1 true AR042015A1 (en) | 2005-06-08 |
Family
ID=33551205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030104114A AR042015A1 (en) | 2002-11-08 | 2003-11-07 | GENETIC MARKER RELATED TO THE CAPACITY OF PRODUCING SULFHYDIC ACID FOR DAMAGED BACTERIAL VACCINES |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR042015A1 (en) |
AU (1) | AU2003304255A1 (en) |
WO (1) | WO2005001069A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006095180A2 (en) * | 2005-03-10 | 2006-09-14 | Ultra Biotech Limited | Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars |
WO2009025888A2 (en) | 2007-05-10 | 2009-02-26 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety |
US8465755B2 (en) | 2007-10-05 | 2013-06-18 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against enteric pathogens |
WO2010045620A1 (en) | 2008-10-17 | 2010-04-22 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
US9163219B2 (en) | 2009-04-14 | 2015-10-20 | Arizona Board Of Regents On Behalf Of Arizona State University | Single expression vector for generation of a virus with a segmented genome |
GB2483595B (en) | 2009-05-22 | 2017-03-29 | The Arizona Board Of Regents For And On Behalf Of Arizona State Univ | Recombinant bacterium and methods of antigen and nucleic acid delivery |
US9045742B2 (en) * | 2009-05-29 | 2015-06-02 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant Edwardsiella bacterium |
US9062297B2 (en) | 2010-01-13 | 2015-06-23 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Yersinia pestis vaccine |
US8889121B2 (en) | 2010-01-22 | 2014-11-18 | The Arizona Board Of Regents For An On Behalf Of Arizona State University | Bacterium comprising a regulated rfaH nucleic acid |
CN101962625A (en) * | 2010-04-29 | 2011-02-02 | 河南科技大学 | Salmonella choleraesuis gene deletion mutant without resistant marker and vaccine thereof |
US9598697B2 (en) | 2010-05-28 | 2017-03-21 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium to decrease tumor growth |
US9303264B2 (en) | 2012-05-18 | 2016-04-05 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Photosynthetic microorganisms expressing thermostable lipase |
US9580718B2 (en) | 2013-06-17 | 2017-02-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Attenuated live bacteria with increased acid resistance and methods of use thereof |
CN104651288A (en) * | 2015-01-07 | 2015-05-27 | 四川农业大学 | Pasteurella multocida attenuated strain deficient in crp as well as construction method and application of attenuated strain |
CN104560854B (en) * | 2015-01-07 | 2018-03-02 | 四川农业大学 | Lack phoP eggs crack detection attenuated strain and its construction method and application |
-
2003
- 2003-11-07 AR ARP030104114A patent/AR042015A1/en unknown
- 2003-11-07 WO PCT/US2003/035696 patent/WO2005001069A1/en not_active Application Discontinuation
- 2003-11-07 AU AU2003304255A patent/AU2003304255A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005001069A1 (en) | 2005-01-06 |
AU2003304255A1 (en) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR042015A1 (en) | GENETIC MARKER RELATED TO THE CAPACITY OF PRODUCING SULFHYDIC ACID FOR DAMAGED BACTERIAL VACCINES | |
Mobley et al. | Helicobacter pylori: physiology and genetics | |
Salanitro et al. | Isolation, culture characteristics, and identification of anaerobic bacteria from the chicken cecum | |
Freundt | Culture media for classic mycoplasmas | |
ES2061519T3 (en) | PROCEDURE FOR THE PRODUCTION OF EICOSAPENTAENOIC ACID. | |
MX2011000793A (en) | Methods, systems and compositions for increased microorganism tolerance to and production of 3-hydroxypropionic acid (3-hp). | |
AR045813A1 (en) | METHOD FOR OBTAINING A BIOLOGICALLY ACTIVE BOTULINIC TOXIN, COMPOSITION THAT INCLUDES CLOSTRIDIUM BOTULINUM AND A CROP MEANS TO PRODUCE A BOTULINAL TOXIN THROUGH SUCH METHOD AND METHOD FOR PREPARING A PHARMACEUTICALLY COMPREHENSIVE PRODUCT COMPOSITION | |
ES2089232T3 (en) | 5-ENOLPIRUVILSIQUIMATO-3-FOSFATO TOLERANT SYNTHASES OF GLYPHOSATE. | |
RU2008147883A (en) | APPLICATION OF LACTIC ACID BACTERIA TO REDUCE CHILDREN'S COLIC | |
KR101589465B1 (en) | Use of bifidobacterium breve cbt br3 strain for promoting growth and nutraceutical composition for promoting growth comprising the same | |
GB0103301D0 (en) | Culture of crypthecodinium cohnii and microorganisms derived therefrom | |
KR20140014369A (en) | Rapid sterility microassay | |
CN105925561A (en) | Breeding method of strong-acid resistant lactic acid bacteria strain | |
CN102061272A (en) | Lactobacillus salivarius SIL1 and application thereof | |
CN106282075A (en) | A kind of fluid medium for cultivating haemophilus parasuis | |
Sánchez-Jiménez et al. | Distribution of pathogenicity islands among Colombian isolates of Salmonella | |
DK1831349T3 (en) | Method of cultivating bacteria to deliver bioactive compounds to the intestine of ruminants | |
TW201538722A (en) | Probiotic strain producing hyaluronic acid and uses thereof | |
BRPI0401947A (en) | Method for producing an l-amino acid and bacteria | |
ES2365798T1 (en) | GENETICALLY PURIFIED GELAN RUBBER. | |
CN103992962A (en) | Streptococcusmutans rnc gene mutant strain and application thereof | |
Raut et al. | Isolation and characterization of protease producing bacteria from upper respiratory tract of wild chicken | |
Kim et al. | Probiotic properties and adsorption of Enterococcus faecalis PSCT3-7 to vermiculite | |
CN201813935U (en) | Bactericidal shoes | |
CN106924229B (en) | Application of the phloretin in preparation treatment chicken necrotizing enterocolitis drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |